REGENTS OF THE UNIVERSITY OF MINNESOTA

• LEIDOS BIOMEDICAL RESEARCH INC

  UEI HV8BH9BPG8Y9

  $8.3M

  Subcontractor to this prime · 1 sub-award · latest Jan 14, 2025

  • National Institutes of Health
  • “MS4 OPT2 - STUDY 3”
• UNIVERSITY OF MONTANA

  UEI DAY7Z8ZD48Q3 · not in the directory yet

  $2.4M

  Subcontractor to this prime · 1 sub-award · latest May 12, 2026

  • National Institutes of Health
  • “VACCINES FOR OPIOD USE DISORDER”
• SEATTLE CHILDREN'S HOSPITAL

  UEI SZ32VTCXM799

  $995.9K

  Subcontractor to this prime · 2 sub-awards · latest Nov 18, 2025

  • National Institutes of Health
  • “STATEMENT OF WORK – YEAR 7 (BASE) – GALE THE GALE LABORATORY WILL PERFORM RNA-SEQ ASSAYS FOR THE NHP IMMUNOLOGIC STUDIES IN YEAR 7. WHOLE BLOOD AND TISSUE SAMPLES WILL BE RECEIVED AT THE GALE LABORATORY AT THE UNIVERSITY OF MINNESOTA FROM LOUIS PICKER (OHSU). RNA-SEQ ASSAYS WILL BE CONDUCTED BY UNIVERSITY OF MINNESOTA GENOME CENTER (UMGC). RNA-SEQ ASSAY TASKS INCLUDE 1) RNA ISOLATION AND RNA QC, 2) RNA-SEQ LIBRARY CONSTRUCTION AND LIBRARY QC, AND 3) GENERATION OF RNA SEQUENCE DATA FROM THE RESULTING MRNA-SEQ LIBRARIES ON A UG 100 PLATFORM. THE GALE LABORATORY WILL CONDUCT COMPUTATIONAL DATA ANALYSIS AND MODELING ON THE RNA-SEQ DATA SETS. IN YEAR 7, THE GALE LAB WILL ANALYZE NHP WHOLE BLOOD AND TISSUE RNA-SEQ DATA SETS THAT WERE GENERATED IN YEAR 7 AND PRIOR PERIODS. THIS ANALYSIS WILL INCLUDE BUT NOT BE LIMITED TO INITIAL DATA QC, GENERATION OF NORMALIZED EXPRESSION MATRICES, DIFFERENTIAL GENE EXPRESSION ANALYSIS, FUNCTIONAL ANALYSIS, CO-EXPRESSION ANALYSIS AND WHEN APPROPRIATE RULE-BASED MODELING.”
  • “THE OVERALL GOAL OF THE IMPAC-TB PROGRAM IS TO INFORM THE RATIONAL DESIGN OF AN EFFECTIVE TB VACCINE BY IDENTIFICATION OF IMMUNE RESPONSES THAT ARE CAPABLE OF CONTROLLING AND POTENTIALLY EVEN ERADICATING MTB. WE WILL ACHIEVE THIS GOAL BY IDENTIFYING AND DISSECTING PROTECTIVE PATHWAYS IN NATURAL AND VACCINE-INDUCED IMMUNITY THROUGH INTEGRATED ANALYSES OF TISSUE-SPECIFIC AND SYSTEMIC IMMUNITY IN MICE, NON-HUMAN PRIMATES (NHP), AND HUMANS. 1. THE GALE LABORATORY WILL CONDUCT RNA-SEQ ASSAYS FOR THE NHP IMMUNOLOGIC STUDIES. IN YEAR 6, THE GALE LABORATORY WILL PERFORM RNA-SEQ ASSAYS ON NHP SAMPLES COLLECTED FROM EXP #1, EXP #2, AND EXP #4. TASKS INCLUDE 1) RECEIVING TISSUE HOMOGENATE SAMPLES RECEIVED AT THE UNIVERSITY OF MINNESOTA FROM LOUIS PICKER (OHSU), 2) ISOLATING RNA FROM THESE SAMPLES AND PERFORMING RNA QC, 3) CONSTRUCTING RNA-SEQ LIBRARIES AND LIBRARY QC USING THE ISOLATED RNA, AND 4) GENERATING RNA SEQUENCE DATA FROM THE RESULTING MRNA-SEQ LIBRARIES. 2. THE GALE LABORATORY WILL CONDUCT COMPUTATIONAL DATA ANALYSIS AND MODELING ON THE RNA-SEQ DATA SETS. IN YEAR 6, THE GALE LAB WILL ANALYZE NHP WHOLE BLOOD RNA-SEQ DATA SETS THAT WERE GENERATED AT UNIVERSITY OF WASHINGTON (GALE LAB) DURING YEAR 5. THIS ANALYSIS WILL INCLUDE BUT NOT BE LIMITED TO INITIAL DATA QC, GENERATION OF NORMALIZED EXPRESSION MATRICES, DIFFERENTIAL GENE EXPRESSION ANALYSIS, FUNCTIONAL ANALYSIS, CO-EXPRESSION ANALYSIS AND WHEN APPROPRIATE RULE-BASED MODELING.”
• FERMI FORWARD DISCOVERY GROUP, LLC

  UEI VLS6K3EVCMW5

  $901.3K

  Subcontractor to this prime · 1 sub-award · latest Jul 16, 2024

  • Department of Energy
  • “LBNF/DUNE PRISM PROTOTYPE”
• ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

  UEI C8H9CNG1VBD9

  $800K

  Subcontractor to this prime · 1 sub-award · latest Feb 25, 2025

  • National Institutes of Health
  • “OPTION 23C: 0258-A485-4609 OPTION 23D: 0258-A486-4609 THE UNIVERSAL INFLUENZA VACCINE TECHNOLOGY LANDSCAPE IS A UNIQUE, OPEN-ACCESS DATABASE OF INFORMATION ON UNIVERSAL, BROADLY PROTECTIVE, AND NEXT-GENERATION INFLUENZA VACCINES, AS DEFINED IN THE INFLUENZA VACCINES R&D ROADMAP, IN CLINICAL AND PRECLINICAL DEVELOPMENT. AS OF MAY 2024, THE LANDSCAPE PROFILED MORE THAN 200 VACCINE CANDIDATES IN THE R&D PIPELINE IN ACADEMIC, GOVERNMENT, AND INDUSTRY LABORATORIES, INCLUDING COVID-INFLUENZA COMBINATION VACCINES IN CLINICAL DEVELOPMENT, ACROSS SIX DIFFERENT VACCINE PLATFORMS. DATA ON EACH VACCINE CANDIDATE ARE SUMMARIZED BY PHASE, PLATFORM, TECHNICAL APPROACH, GOAL, AND STATUS OF DEVELOPMENT. THE LANDSCAPE IS ONLINE AND OPEN ACCESS, AND THE ENTIRE DATASET CAN BE DOWNLOADED AS A CSV FILE. A SMALL GROUP OF SUBJECT-MATTER EXPERTS IN INFLUENZA VACCINE R&D AND/OR VACCINE DATABASE DEVELOPMENT PROVIDES ADVICE ON THE DEVELOPMENT OF THE LANDSCAPE. THE OBJECTIVE OF THIS PROJECT IS TO CONTINUE DEVELOPING AND MAINTAINING INFORMATION ON THE LANDSCAPE TO INCLUDE AN UP-TO-DATE, COMPREHENSIVE, AND ACCURATE OVERVIEW OF VACCINE CANDIDATES IN PRECLINICAL DEVELOPMENT FOR UNIVERSAL, BROADLY PROTECTIVE, AND NEXT-GENERATION INFLUENZA VACCINES. SPECIFIC ACTIVITIES: 1. COLLECT AND CURATE INFORMATION ON UNIVERSAL, BROADLY PROTECTIVE, AND NEXT-GENERATION INFLUENZA VACCINES TECHNOLOGIES IN PRECLINICAL DEVELOPMENT FROM A WIDE RANGE OF PUBLICLY AVAILABLE SOURCES. CONTINUE RESEARCH ON UNIVERSAL, BROADLY PROTECTIVE, AND NEXT-GENERATION INFLUENZA VACCINE TECHNOLOGIES; MONITOR KEY SOURCES OF INFORMATION FROM THE SCIENTIFIC LITERATURE, PREPRINT SERVERS, AND INDUSTRY WEBSITES AND NEWS SOURCES; AND CROSSCHECK DATA ON VACCINE TECHNOLOGIES IN THE DATABASE. 2. UPLOAD NEW OR REVISED INFORMATION ON THE IVR LANDSCAPE WEBSITE ON A WEEKLY BASIS, FOR DISPLAY IN THE SNAPSHOT GRAPHIC AND DATABASE TABLE, AND MONITOR DATA FOR COMPLETENESS AND ACCURACY. 3. DISSEMINATE INFORMATION ON R&D OF INFLUENZA CANDIDAT”
• REGENTS OF THE UNIVERSITY OF MICHIGAN

  UEI GNJ7BBP73WE9 · not in the directory yet

  $781.8K

  Subcontractor to this prime · 1 sub-award · latest Mar 29, 2024

  • Defense Advanced Research Projects Agency
  • “PHASE I TRACK II TRACK 2 TASK 3 NATURALLY OCCURRING DEEP EUTECTIC SYSTEMS SUBTASK 3.1: NADES-FORMING COMBINATIONS; UMN; M1-M12 SUBTASK 3.2: THERMAL ANALYSIS AND WATER ACTIVITY; UMN; M3-M12 PHASE I INTEGRATION INTEGRATION OF TRACKS 1 AND 2 TASK 12 ICE INHIBITION AND ICE INDUCTION PERFORMANCE OPTIMIZATION SUBTASK 12.1: LOW-TEMPERATURE RAMAN SPECTROSCOPY; PHASE 2 TASK 19FROSTBITE PREVENTION SUBTASK 19.1IN VITRO FROSTBITE PREVENTION”
• UNIVERSITY OF ALABAMA AT BIRMINGHAM

  UEI YND4PLMC9AN7

  $694.6K

  Subcontractor to this prime · 2 sub-awards · latest Aug 6, 2026

  • National Institutes of Health
  • “TASK AREA B.1 LIMITED EXAMINATION OF THE CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA)”
  • “THE ADVANCED RESEARCH AND DIAGNOSTIC LABORATORY WILL BE RESPONSIBLE FOR THE FOLLOWING TASKS IN THE STUDY: (1) ARRANGE FOR TRANSFER OF 28 STUDY-OWNED ULTRALOW FREEZERS, CONTAINING PREVIOUSLY COLLECTED BIOSPECIMEN ALIQUOTS, FROM THEIR CURRENT LOCATION IN BURIEN, WA; (2) RECEIVE DELIVERY OF 28 STUDY-OWNED ULTRALOW FREEZER AND THEIR CONTENTS; (3) CONDUCT A FULL RE-INVENTORY OF ALL PREVIOUSLY COLLECTED BIOSPECIMENS; (4) CONSOLIDATE ALL PREVIOUSLY COLLECTED BIOSPECIMENS INTO 20 STUDY-OWNED ULTRALOW FREEZERS; (5) INCORPORATE UPDATED INVENTORY DETAILS INTO ARDL’S BIOREPOSITORY AND INVENTORY MANAGEMENT SYSTEM; (6) MAINTAIN FROZEN STORAGE OF ALL PREVIOUSLY COLLECTED BIOSPECIMENS IN 20 STUDY-OWNED ULTRALOW FREEZERS; (7) AS ADDITIONAL BIOSPECIMENS ARE COLLECTED, INCLUDE THEM IN THE OVERALL CARDIA BIOREPOSITORY. THIS INCLUDES FROZEN STORAGE IN STUDY-OWNED ULTRALOW FREEZERS, AND MAINTAINING RECORDS FOR THE NEW BIOSPECIMENS IN ARDL’S BIOREPOSITORY AND INVENTORY MANAGEMENT SYSTEM; AND (8) PROVIDE INVENTORY UPDATES TO THE CARDIA COORDINATING CENTER AS REQUESTED.”
• UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL

  UEI D3LHU66KBLD5

  $682.1K

  Subcontractor to this prime · 1 sub-award · latest Mar 14, 2025

  • National Institutes of Health
  • “THE UNIVERSITY OF MINNESOTA (UM) RESEARCHERS WILL BE THE CENTRAL LABORATORY FOR THE STUDY TITLED "HISPANIC COMMUNITY HEALTH STUDY-STUDY OF LATINOS (HCHS-SOL) COORDINATION CENTER". UM WILL COMPLETE THE FOLLOWING TASKS: A5. ESTABLISH AND MANAGE THE BIOLOGICAL SPECIMEN REPOSITORY; A5A. MAINTAIN THE HCHS/SOL BIOLOGIC SPECIMEN REPOSITORY IN ACCORDANCE WITH HCHS/SOL POLICIES AND PROCEDURES; A5B. INCORPORATE SURPLUS SPECIMENS FROM ANCILLARY STUDIES; A5C. TRACK SAMPLES; A5D. PROVIDE SPECIMENS TO APPROVED INVESTIGATORS IN ACCORDANCE WITH STUDY POLICIES AND PROCEDURES; A5E. CONDUCT QUALITY MANAGEMENT PROCEDURES; B2.3. PLAN AND CONDUCT THE RECEIPT AND PROCESSING OF COLLECTED BLOOD AND URINE SAMPLES; B2.5. TRAINING OF RELEVANT STAFF AT ALL FIELD CENTERS; C.3. PROVIDE SMOOTH TRANSFER OF ALL BIOLOGICAL SAMPLES; C.4. PREPARE AN APPLICATION FOR TRANSFER OF BIOLOGICAL SPECIMENS TO THE NHLBI BIOSPECIMEN REPOSITORY; C.5. SHIP ALL BIOLOGICAL SAMPLES TO THE NHLBI BIOSPECIMEN REPOSITORY AND/OR OTHER BIOREPOSITORIES.”
• TRUSTEES OF THE COLORADO SCHOOL OF MINES

  UEI JW2NGMP4NMA3

  $300K

  Subcontractor to this prime · 1 sub-award · latest Sep 22, 2026

  • Department of the Army
  • “CENTER FOR PFAS REMEDIAL TECHNOLOGY ENGINEERING”
• NORTHWESTERN UNIVERSITY

  UEI KG76WYENL5K1

  $190.3K

  Subcontractor to this prime · 1 sub-award · latest Jan 21, 2026

  • Department of the Army
  • “SCALABLE ULTRA-LOW VARIATION ANALOG-TIME NEURAL NETWORK (S-UATN) ACCELERATOR”

No reported sub-awards as a prime contractor.

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.

No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).

The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.